Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
NCT Number: NCT03767166
This is a prospective, phase II, single-centre, non-randomised, single-arm study, enrolling patients with benign and malignant bilio-pancreatic diseases with an indication to biliary or pancreatic plastic stent positioning during ERCP.
On procedure day, the study team will confirm that the patient meets all the inclusion criteria and none of the exclusion criteria.
The patient will undergo the ABS insertion and monitored and follow-up accordingly to biodegration variant.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rozzano, Milano, 20089, Italy
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biodegradable biliary and pancreatic stents placement
Time frame: 24 Months
Istituto Clinico Humanitas
Other
A Prospective, Single Arm Study to Evaluate the Feasibility of the Archimedes Biodegradable Biliary and Pancreatic Stents Placement
Acronym: ARCHIMEDES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04205058
Bowel Dysfunction, Digestive System Diseases
Verona, Italy
View Trial DetailsNCT03269994
Digestive System Diseases, Digestive System Neoplasms
Sacramento, California, United States
View Trial DetailsNCT02717650
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis
Melbourne, Victoria, Australia
View Trial DetailsNCT07022639
Digestive System Diseases, Pancreatic Diseases
Sankt Gallen, St.Gallen, Switzerland
View Trial Details